Royal Bank Of Canada Upgrades Doximity (NYSE:DOCS) to Moderate Buy

Doximity (NYSE:DOCS) was upgraded by equities research analysts at Royal Bank Of Canada to a “moderate buy” rating in a report issued on Thursday,Zacks.com reports.

Other research analysts also recently issued research reports about the company. Barclays upgraded Doximity to a “strong-buy” rating in a research note on Monday, December 8th. The Goldman Sachs Group upgraded shares of Doximity from a “strong sell” rating to a “hold” rating in a research report on Friday. Wall Street Zen downgraded shares of Doximity from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Doximity in a research report on Wednesday, December 24th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Doximity presently has an average rating of “Buy”.

Doximity Price Performance

NYSE:DOCS opened at $43.85 on Thursday. Doximity has a 1 year low of $43.21 and a 1 year high of $85.21. The firm has a market capitalization of $8.26 billion, a price-to-earnings ratio of 34.80, a PEG ratio of 2.03 and a beta of 1.39.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.